Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesConventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis
Journal of Rheumatology, 07/02/09
García-gómez C et al. - Rheumatoid arthritis (RA) patients undergoing antirheumatic therapy display a nonatherogenic conventional lipid profile (high HDL-c, low apolipoprotein B concns, and low apolipoprotein B/apolipoprotein A-I ratio). This may be counteracted by the high prevalence of hyperlipoproteinemia(a) observed in these pts.
Methods- An evaluation of conventional lipid risk factors and lipoprotein(a) in treated RA pts
- 122 pts; lipid profiles of pts were compared with a control group, matched for sex, age, menopausal status, and BMI
- Excess lipoprotein(a) was defined by a serum concn >0.3 g/l
- High-density lipoprotein cholesterol (HDL-c) concns were higher in pre- and postmenopausal women with RA vs controls
- All RA pts had lower levels of apolipoprotein B and apolipoprotein B/apolipoprotein A-I ratio
- Postmenopausal women with RA also had lower low-density lipoprotein cholesterol and total cholesterol levels vs controls
- No differences observed in serum levels of apolipoprotein A-I and triglyceride
- All RA pts had higher lipoprotein(a) values than controls
- 56% men and 53% and 54% pre- and postmenopausal women with RA, respectively, had hyperlipoproteinemia(a)
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up
Scandinavian Journal of Rheumatology , 09/28/09
Sponsor
Article Search
Sponsor